FDA grants orphan drug status to innovative Chinese treatment for eye cancer - PRESS AI WORLD
PRESSAI
Recent Posts
side-post-image
side-post-image
Politics

FDA grants orphan drug status to innovative Chinese treatment for eye cancer

share-iconFriday, January 03 comment-icon2 weeks ago 6 views
News sources:
scmpSCMP
FDA grants orphan drug status to innovative Chinese treatment for eye cancer

Credited from: SCMP

  • The FDA has granted orphan drug designation to a new eye cancer treatment developed by Chinese researchers, facilitating its clinical transition.
  • This aptamer drug conjugate (ApDC) is recognized as the world's first gene-based treatment of its kind for uveal melanoma.
  • About 2,500 people in the US are diagnosed with this rare cancer annually, often in advanced stages due to subtle early symptoms.
  • The new treatment aims to offer a safer and more effective alternative to traditional therapies, which can result in significant damage to eye tissues.
  • The research team is moving forward with clinical trials, with plans to bring the treatment to market expeditiously.

For more details, visit the original article here.

SHARE THIS ARTICLE:

nav-post-picture
nav-post-picture